Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

viatris healthcare limited, Írsko - flutikazón,kombinácie - 24 - antihistaminica, histamin

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

viatris healthcare limited, Írsko - flutikazón,kombinácie - 24 - antihistaminica, histamin

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

viatris healthcare limited, Írsko - vápnik, kombinácie s vitamínom d a/alebo s inými liečivami - 39 - soli a ionty pro p.o. a parent. aplikÁciu

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

viatris healthcare limited, Írsko - vápnik, kombinácie s vitamínom d a/alebo s inými liečivami - 39 - soli a ionty pro p.o. a parent. aplikÁciu

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

viatris healthcare limited, Írsko - moklobemid - 30 - antidepressiva

Európska únia - slovenčina - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotické činidlá - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

viatris limited, Írsko - apixabán - 16 - anticoagulantia (fibrinolytica, antifibrinol.)

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

viatris limited, Írsko - flutikazón,kombinácie - 24 - antihistaminica, histamin

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

viatris healthcare limited, Írsko - azelastín - 24 - antihistaminica, histamin

Európska únia - slovenčina - EMA (European Medicines Agency)

viatris healthcare limited - imikvimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotiká a chemoterapeutiká na dermatologické použitie - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.